Parabolic Drugs

parabolicdrugs.com

Parabolic Drugs Limited is a vertically integrated, research based, Pharmaceutical manufacturer and exporter, specializing in development and manufacturing of Active Pharmaceutical Ingredients (API) and API intermediates. The Company has dedicated facilities for Custom Research and API manufacturing at its 4 locations, 2 in Haryana (India) and 2 in Punjab (India) and exporting to over 51 countries across the globe from its WHO-GMP facilities. Parabolic has a wide Product basket, ranging from Oral and Sterile Semi Synthetic Penicillin API, Oral and Sterile Cephalosporin API in antibiotic segment to non-antibiotic API in the Cardiovascular, NSAID, Anti-Hypertensive and Osteoporosis segments.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

HALOZYME ANNOUNCES APPROVAL OF ROCHE'S TECENTRIQ® SUBCUTANEOUS (SC) WITH ENHANZE® IN GREAT BRITAIN

prnewswire | August 29, 2023

news image

Halozyme Therapeutics, Inc. announced the approval of Roche's Tecentriq® SC (atezolizumab), using Halozyme's ENHANZE® drug delivery technology, by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. Tecentriq® subcutaneous (SC) is co-formulated with Halozyme's proprietary recombinant human hyaluronidase enzyme, rHuPH20, allowing for subcutaneous delivery, which takes approximately seven minutes, compared with 30-60 minutes for intravenou...

Read More

Business Insights, PHARMACY MARKET

PATHAI ANNOUNCES PATHEXPLORE, AN AI-POWERED PATHOLOGY PANEL TO UNLOCK UNTAPPED INSIGHTS FROM THE TUMOR MICROENVIRONMENT

Prnewswire | April 05, 2023

news image

PathAI, a global leader in AI-powered pathology, announced the launch of PathExplore™, the world's first structured, standardized and scalable panel of human interpretable features (HIFs) offering unprecedented resolution of the tumor microenvironment (TME) from H&E whole-slide images. Powered by artificial intelligence, PathExplore1 spatially characterizes the TME with single-cell resolution, giving oncology drug developers the ability to unlock insights to inform the next p...

Read More

NOVARTIS DEMANDS OUTSIDE COUNSEL MAKE TOUGH DIVERSITY GUARANTEES

Bloomberg Law | February 13, 2020

news image

Novartis AG is demanding that its 22 “preferred” Big Law firms make specific diverse staffing commitments for each engagement with the pharma giant or face punishment in the form of reduced payments. Through the new program announced on Wednesday, Novartis is also requiring its outside counsel to commit that at least 30% of billable associate time and 20% of partner time will be provided by women, racially or ethnically diverse professionals, or members of the LGBT community. If firm...

Read More

Business Insights

AZZUR GROUP ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Azzur Group, LLC | January 13, 2022

news image

To support rapid company growth and best meet the demands of the business, Azzur Group announces new executive leadership appointments. Originally founded in Philadelphia in 2010, Azzur is a market-leading provider of GxP services for the pharmaceutical, biotechnology, medical device, and healthcare industries with offices and on-demand cleanrooms locations throughout the United States. Today, the organization provides comprehensive GxP solutions through its on-demand cleanrooms, consulting and ...

Read More
news image

Pharmacy Market

HALOZYME ANNOUNCES APPROVAL OF ROCHE'S TECENTRIQ® SUBCUTANEOUS (SC) WITH ENHANZE® IN GREAT BRITAIN

prnewswire | August 29, 2023

Halozyme Therapeutics, Inc. announced the approval of Roche's Tecentriq® SC (atezolizumab), using Halozyme's ENHANZE® drug delivery technology, by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. Tecentriq® subcutaneous (SC) is co-formulated with Halozyme's proprietary recombinant human hyaluronidase enzyme, rHuPH20, allowing for subcutaneous delivery, which takes approximately seven minutes, compared with 30-60 minutes for intravenou...

Read More
news image

Business Insights, PHARMACY MARKET

PATHAI ANNOUNCES PATHEXPLORE, AN AI-POWERED PATHOLOGY PANEL TO UNLOCK UNTAPPED INSIGHTS FROM THE TUMOR MICROENVIRONMENT

Prnewswire | April 05, 2023

PathAI, a global leader in AI-powered pathology, announced the launch of PathExplore™, the world's first structured, standardized and scalable panel of human interpretable features (HIFs) offering unprecedented resolution of the tumor microenvironment (TME) from H&E whole-slide images. Powered by artificial intelligence, PathExplore1 spatially characterizes the TME with single-cell resolution, giving oncology drug developers the ability to unlock insights to inform the next p...

Read More
news image

NOVARTIS DEMANDS OUTSIDE COUNSEL MAKE TOUGH DIVERSITY GUARANTEES

Bloomberg Law | February 13, 2020

Novartis AG is demanding that its 22 “preferred” Big Law firms make specific diverse staffing commitments for each engagement with the pharma giant or face punishment in the form of reduced payments. Through the new program announced on Wednesday, Novartis is also requiring its outside counsel to commit that at least 30% of billable associate time and 20% of partner time will be provided by women, racially or ethnically diverse professionals, or members of the LGBT community. If firm...

Read More
news image

Business Insights

AZZUR GROUP ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Azzur Group, LLC | January 13, 2022

To support rapid company growth and best meet the demands of the business, Azzur Group announces new executive leadership appointments. Originally founded in Philadelphia in 2010, Azzur is a market-leading provider of GxP services for the pharmaceutical, biotechnology, medical device, and healthcare industries with offices and on-demand cleanrooms locations throughout the United States. Today, the organization provides comprehensive GxP solutions through its on-demand cleanrooms, consulting and ...

Read More

Resources

resource image

Research, Business Insights

Navigating a Stringent Regulatory Landscape

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us